Sign Up Today and Learn More About Kyverna Therapeutics Stock
Invest in or calculate the value of your shares in Kyverna Therapeutics or other pre-IPO companies through EquityZen's platform.
Kyverna Therapeutics Stock
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
About Kyverna Therapeutics Stock
Founded
2018
Headquarters
Berkeley, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Kyverna Therapeutics Press Mentions
Stay in the know about the latest news on Kyverna Therapeutics
US IPO Weekly Recap: Autoimmune biotech Kyverna Therapeutics gains 37% in a 6 IPO week
renaissancecapital • Feb 10, 2024
Kyverna Therapeutics upsizes proposed IPO to $200M
seekingalpha • Feb 05, 2024
ARCH-backed startup AIRNA launches with $30M for RNA ...
endpts • Jan 25, 2024
Kyverna's CAR T-Cell Therapy Expands Autoimmune ...
ajmc • Jan 25, 2024
Exclusive: Autoimmune CAR-T biotech Kyverna Therapeutics is considering an IPO next month
endpts • Jan 13, 2024
Kyverna Therapeutics Management
Leadership team at Kyverna Therapeutics
Senior Vice President, Head of Research
Tom Van Blarcom
Board Observer
Heba Nowyhed
Join now and verify your accreditation status to gain access to:
- Kyverna Therapeutics current valuation
- Kyverna Therapeutics stock price
- Available deals in Kyverna Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Kyverna Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Kyverna Therapeutics through EquityZen funds. These investments are made available by existing Kyverna Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Kyverna Therapeutics stock?
Shareholders can sell their Kyverna Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
